Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-007053

Chief Business Officer acquired 3,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2023-03-01 Grant or award +1,600 $19.86 $31,776 17,983 D
Robb Gary Charles Chief Business Officer 2023-03-01 Grant or award +1,600 19,583 D
Loading xslF345X03/doc4.xml…